Bonus BioGroup Ltd. (BONS.TA)
ILA 17.8
(0.56%)
ILA 17.8
(0.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.77 Million ILS | 95.73% |
| 2022 | -41.67 Million ILS | 37.9% |
| 2021 | -67.1 Million ILS | -513.82% |
| 2020 | -10.93 Million ILS | -289.43% |
| 2019 | 5.77 Million ILS | 166.79% |
| 2018 | -8.64 Million ILS | -217.1% |
| 2017 | -2.72 Million ILS | -94.5% |
| 2016 | -1.4 Million ILS | 68.24% |
| 2015 | -4.41 Million ILS | -351.95% |
| 2014 | -976 Thousand ILS | -26.1% |
| 2013 | -774 Thousand ILS | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -5.67 Million ILS | -218.77% |
| 2024 Q2 | -3.42 Million ILS | 39.68% |
| 2023 FY | -1.77 Million ILS | 95.73% |
| 2023 Q1 | -33.81 Million ILS | 18.84% |
| 2023 Q2 | -27.25 Million ILS | 19.41% |
| 2023 Q3 | -11.79 Million ILS | 56.73% |
| 2023 Q4 | -1.77 Million ILS | 84.92% |
| 2022 Q2 | -56.72 Million ILS | 5.18% |
| 2022 FY | -41.67 Million ILS | 37.9% |
| 2022 Q3 | -48.74 Million ILS | 14.07% |
| 2022 Q1 | -59.82 Million ILS | 10.85% |
| 2022 Q4 | -41.67 Million ILS | 14.51% |
| 2021 FY | -67.1 Million ILS | -513.82% |
| 2021 Q4 | -67.1 Million ILS | 14.73% |
| 2021 Q1 | -83.82 Million ILS | -666.74% |
| 2021 Q2 | -80.94 Million ILS | 3.43% |
| 2021 Q3 | -78.69 Million ILS | 2.78% |
| 2020 Q1 | -1.95 Million ILS | -133.93% |
| 2020 Q2 | 1.35 Million ILS | 169.31% |
| 2020 Q3 | 2.9 Million ILS | 113.71% |
| 2020 Q4 | -10.93 Million ILS | -476.97% |
| 2020 FY | -10.93 Million ILS | -289.43% |
| 2019 Q2 | 4.79 Million ILS | 78.82% |
| 2019 Q3 | 2.87 Million ILS | -40.01% |
| 2019 Q1 | 2.68 Million ILS | 131.04% |
| 2019 FY | 5.77 Million ILS | 166.79% |
| 2019 Q4 | 5.77 Million ILS | 100.59% |
| 2018 Q3 | -9.51 Million ILS | -27.96% |
| 2018 FY | -8.64 Million ILS | -217.1% |
| 2018 Q2 | -7.43 Million ILS | -86.11% |
| 2018 Q1 | -3.99 Million ILS | -46.61% |
| 2018 Q4 | -8.64 Million ILS | 9.18% |
| 2017 Q4 | -2.72 Million ILS | -33.64% |
| 2017 FY | -2.72 Million ILS | -94.5% |
| 2017 Q1 | -2.24 Million ILS | -60.39% |
| 2017 Q2 | -3.26 Million ILS | -45.35% |
| 2017 Q3 | -2.03 Million ILS | 37.57% |
| 2016 Q4 | -1.4 Million ILS | 62.09% |
| 2016 FY | -1.4 Million ILS | 68.24% |
| 2016 Q2 | -2.24 Million ILS | 38.93% |
| 2016 Q1 | -3.66 Million ILS | 16.84% |
| 2016 Q3 | -3.69 Million ILS | -65.0% |
| 2015 Q2 | -2.89 Million ILS | -58.72% |
| 2015 Q3 | -1.14 Million ILS | 60.35% |
| 2015 Q4 | -4.41 Million ILS | -284.23% |
| 2015 Q1 | -1.82 Million ILS | -86.89% |
| 2015 FY | -4.41 Million ILS | -351.95% |
| 2014 Q1 | -328 Thousand ILS | 57.62% |
| 2014 Q4 | -976 Thousand ILS | -56.16% |
| 2014 FY | -976 Thousand ILS | -26.1% |
| 2014 Q3 | -625 Thousand ILS | -26.77% |
| 2014 Q2 | -493 Thousand ILS | -50.3% |
| 2013 FY | -774 Thousand ILS | 0.0% |
| 2013 Q1 | -549 Thousand ILS | 0.0% |
| 2013 Q2 | -480 Thousand ILS | 12.57% |
| 2013 Q3 | -318 Thousand ILS | 33.75% |
| 2013 Q4 | -774 Thousand ILS | -143.4% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Matricelf Ltd | -835 Thousand ILA | -113.054% |